Page 6 - Nitin Joshi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article SAN CARLOS, Calif., Feb. 16, 2021 /PRNewswire/ -- CAGE Bio Inc., an innovative biotechnology company focused on developing innovative therapies for infection, inflammation and immunology, announced the closing of a $7.2 million over-subscribed Series A financing.  The investment was led by professional and angel investor groups consisting of current and former pharmaceutical executives and physicians.  CAGE Bio's mission is to translate ionic liquids into transformational consumer healthcare and prescription therapeutics.  The financing will enable CA...

New Nanoparticle Platform Could Help Treat Various Neurological Disorders Written by AZoNanoJan 4 2021 Over the last few decades, scientists have established the biological pathways that cause neurodegenerative diseases and have created potential molecular agents to target these pathways. Yet, there has been a delay in translating these discoveries into clinically approved treatments, partially due to the challenges faced by researchers in delivering therapeutics into the brain through the blood-brain barrier (BBB). To enable the successful delivery of therapeutic agents into the brain, a gro...

To treat brain disorder, scientists develop nanoparticle drug-delivery system To treat brain disorder, scientists develop nanoparticle drug-delivery system Last Updated: Sun, Jan 3rd, 2021, 07:48:05hrs Washington [US], January 3 (ANI): To facilitate successful delivery of therapeutic agents to the brain, a team of bioengineers, physicians, and collaborators at Brigham and Women's Hospital and Boston Children's Hospital created a nanoparticle platform, which can facilitate therapeutically effective delivery of encapsulated agents in mice with a physically breached or intact the blood-brain bar...

Brigham City [US], January 2 (ANI): A study led by researchers of Brigham and Women's Hospital claims that technology could potentially offer a variety of treatments for human neurological disorders.

 E-Mail Use of the delivery system in mouse models results in unprecedented siRNA penetration across the intact blood brain barrier Technology could offer potential for a variety of human neurological disorders In the past few decades, researchers have identified biological pathways leading to neurodegenerative diseases and developed promising molecular agents to target them. However, the translation of these findings into clinically approved treatments has progressed at a much slower rate, in part because of the challenges scientists face in delivering therapeutics across the blood-brain ba...